FI922620A - Peptidderivat, foerfarande foer dess framstaellning, ett farmaceutisk preparat innehaollande detta och foerfarande foer behandling av glaukoma. - Google Patents

Peptidderivat, foerfarande foer dess framstaellning, ett farmaceutisk preparat innehaollande detta och foerfarande foer behandling av glaukoma. Download PDF

Info

Publication number
FI922620A
FI922620A FI922620A FI922620A FI922620A FI 922620 A FI922620 A FI 922620A FI 922620 A FI922620 A FI 922620A FI 922620 A FI922620 A FI 922620A FI 922620 A FI922620 A FI 922620A
Authority
FI
Finland
Prior art keywords
foerfarande foer
pharmaceutisk
peptidderivat
glaukoma
detta
Prior art date
Application number
FI922620A
Other languages
English (en)
Finnish (fi)
Other versions
FI922620A0 (fi
Inventor
Fred Widmer
Kailash Kumar Gauri
Stig Aasmul-Olsen
Original Assignee
Carlbiotech Ltd As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carlbiotech Ltd As filed Critical Carlbiotech Ltd As
Publication of FI922620A0 publication Critical patent/FI922620A0/fi
Publication of FI922620A publication Critical patent/FI922620A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI922620A 1989-12-07 1992-06-05 Peptidderivat, foerfarande foer dess framstaellning, ett farmaceutisk preparat innehaollande detta och foerfarande foer behandling av glaukoma. FI922620A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK615889A DK167813B1 (da) 1989-12-07 1989-12-07 Pentapeptidderivat, farmaceutisk acceptable salte heraf, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat
PCT/DK1990/000322 WO1991009053A1 (en) 1989-12-07 1990-12-07 Peptide derivative, process for the preparation thereof, pharmaceutical preparation containing it and method for treatment of glaucoma

Publications (2)

Publication Number Publication Date
FI922620A0 FI922620A0 (fi) 1992-06-05
FI922620A true FI922620A (fi) 1992-06-05

Family

ID=8147734

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922620A FI922620A (fi) 1989-12-07 1992-06-05 Peptidderivat, foerfarande foer dess framstaellning, ett farmaceutisk preparat innehaollande detta och foerfarande foer behandling av glaukoma.

Country Status (12)

Country Link
US (1) US5411942A (ja)
EP (1) EP0504207B1 (ja)
JP (1) JPH05504336A (ja)
KR (1) KR927003631A (ja)
AT (1) ATE149517T1 (ja)
CA (1) CA2069449A1 (ja)
DE (1) DE69030100D1 (ja)
DK (1) DK167813B1 (ja)
FI (1) FI922620A (ja)
HU (1) HUT61322A (ja)
LV (1) LV10107B (ja)
WO (1) WO1991009053A1 (ja)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776892A (en) * 1990-12-21 1998-07-07 Curative Health Services, Inc. Anti-inflammatory peptides
DK53291D0 (da) * 1991-03-25 1991-03-25 Carlbiotech Ltd As Smaa peptider og peptidrelaterede stoffer samt farmaceutiske praeparater indeholdende saadanne forbindelser
DK53191D0 (da) * 1991-03-25 1991-03-25 Carlbiotech Ltd As Organosvovlforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
US5773413A (en) * 1993-06-04 1998-06-30 Demeter Biotechnologies, Ltd. Method of combating mammalian neoplasias, and lytic peptides therefor
US5968904A (en) * 1993-06-04 1999-10-19 Demegen, Inc. Modified arginine containing lytic peptides and method of making the same by glyoxylation
US5561107A (en) * 1993-06-04 1996-10-01 Demeter Biotechnologies, Ltd. Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
TR199701526T1 (xx) 1995-06-07 1998-03-21 Glaxo Group Limited Bir trombopoietin resept�r�ne ba�lanan peptitler ve bile�ikler.
US7091311B2 (en) * 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
GB9818938D0 (en) * 1998-08-28 1998-10-21 Alpharma As Bioactive peptides
US8283315B2 (en) * 1998-08-28 2012-10-09 Lytix Biopharma As Inhibition of tumour growth
NZ566812A (en) 2002-09-18 2009-07-31 Ortho Mcneil Pharm Inc Methods of increasing platelet and hematopoietic stem cell production
US20040171554A1 (en) * 2003-02-07 2004-09-02 Genentech, Inc. Compositions and methods for enhancing apoptosis
US8076060B2 (en) * 2003-08-04 2011-12-13 Emil William Chynn Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma
US7723295B2 (en) * 2003-08-28 2010-05-25 Ortho-Mcneil Pharmaceutical, Inc. Peptides and compounds that bind to a receptor
NZ545455A (en) * 2003-08-28 2009-02-28 Ortho Mcneil Pharm Inc Peptides and compounds that bind to thrombopoietin receptors
JP5122275B2 (ja) * 2004-03-23 2013-01-16 ジェネンテック， インコーポレイテッド Ｉａｐのアザビシクロ−オクタンインヒビター
EP1735307B1 (en) 2004-04-07 2012-08-29 Novartis AG Inhibitors of iap
RU2401840C2 (ru) * 2004-07-02 2010-10-20 Дженентек, Инк. Ингибиторы iap
US20060210542A1 (en) * 2004-08-16 2006-09-21 Yurkow Edward J Use of TPO mimetic compounds and pharmaceutical compositions in the treatment of anemia
US20060167066A1 (en) * 2004-12-20 2006-07-27 Genentech, Inc. Pyrrolidine inhibitors of IAP
NZ594746A (en) * 2005-12-19 2013-03-28 Genentech Inc Inhibitors of iap
PE20110218A1 (es) 2006-08-02 2011-04-01 Novartis Ag DERIVADOS DE 2-OXO-ETIL-AMINO-PROPIONAMIDA-PIRROLIDIN-2-IL-SUSTITUIDOS COMO INHIBIDORES DEL ENLACE DE LA PROTEINA Smac AL INHIBIDOR DE LA PROTEINA DE APOPTOSIS
CN101605786A (zh) * 2006-12-19 2009-12-16 健泰科生物技术公司 细胞凋亡抑制剂的咪唑并吡啶抑制剂
CA2682738A1 (en) * 2007-04-16 2008-10-23 Momenta Pharmaceuticals, Inc. Defined glycoprotein products and related methods
TWI432212B (zh) * 2007-04-30 2014-04-01 Genentech Inc Ｉａｐ抑制劑
KR20100110870A (ko) * 2008-01-11 2010-10-13 제넨테크, 인크. Ｉａｐ의 억제제
US8835393B2 (en) 2008-08-02 2014-09-16 Genentech, Inc. Inhibitors of IAP
EA201170344A1 (ru) * 2008-08-16 2011-08-30 Дженентек, Инк. Азаиндольные ингибиторы iap
CN102869784A (zh) 2010-04-07 2013-01-09 动量制药公司 高甘露糖聚糖
CN103782168B (zh) 2011-03-12 2016-03-16 动量制药公司 在糖蛋白产品中包含n-乙酰己糖胺的n-聚醣
WO2013181575A2 (en) 2012-06-01 2013-12-05 Momenta Pharmaceuticals, Inc. Methods related to denosumab
US10450361B2 (en) 2013-03-15 2019-10-22 Momenta Pharmaceuticals, Inc. Methods related to CTLA4-Fc fusion proteins
ES2708759T3 (es) 2013-05-13 2019-04-11 Momenta Pharmaceuticals Inc Procedimientos para el tratamiento de la neurodegeneración
US20160257754A1 (en) 2013-10-16 2016-09-08 Momenta Pharmaceuticals Inc. Sialylated glycoproteins
AU2021241476A1 (en) * 2020-03-25 2022-11-03 Aufbau Medical Innovations Limited Processes and agents for glaucoma

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4457489A (en) * 1981-07-13 1984-07-03 Gilmore Samuel E Subsea fluid conduit connections for remote controlled valves
DE3360065D1 (en) * 1982-03-08 1985-03-28 Schering Corp Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
US4559340A (en) * 1983-11-25 1985-12-17 Schering Corporation Antihypertensive agents
US4634698A (en) * 1984-09-24 1987-01-06 Schering Corporation Antiglaucoma agents
WO1986004217A2 (en) * 1985-01-18 1986-07-31 Kailash Kumar Gauri Protein hydrolysates, production process and drugs containing th em
IL86386A0 (en) * 1987-05-21 1988-11-15 Merrell Dow Pharma Novel anf derivatives
US4927807A (en) * 1987-10-06 1990-05-22 Abbott Laboratories Glaucoma treatment
GB8728560D0 (en) * 1987-12-07 1988-01-13 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
WO1991009053A1 (en) 1991-06-27
DK167813B1 (da) 1993-12-20
JPH05504336A (ja) 1993-07-08
LV10107A (lv) 1994-05-10
HUT61322A (en) 1992-12-28
US5411942A (en) 1995-05-02
DE69030100D1 (de) 1997-04-10
CA2069449A1 (en) 1991-06-08
EP0504207B1 (en) 1997-03-05
AU636427B2 (en) 1993-04-29
ATE149517T1 (de) 1997-03-15
EP0504207A1 (en) 1992-09-23
FI922620A0 (fi) 1992-06-05
KR927003631A (ko) 1992-12-18
LV10107B (en) 1995-02-20
DK615889D0 (da) 1989-12-07
HU9201883D0 (en) 1992-09-28
DK615889A (da) 1991-06-08
AU6898991A (en) 1991-07-18

Similar Documents

Publication Publication Date Title
FI922620A (fi) Peptidderivat, foerfarande foer dess framstaellning, ett farmaceutisk preparat innehaollande detta och foerfarande foer behandling av glaukoma.
PT723538E (pt) Compostos triciclicos de carbamato uteis para a ainibicao da funcao da proteina g e para o tratamento de doencas proliferativas
FI113644B (fi) Menetelmä terapeuttisesti aktiivisten N-substituoitujen 3- atsabisykloalkaanijohdannaisten valmistamiseksi
CA2052608A1 (en) Method of making a modified proteinaceous product and composition thereof
DK366889A (da) Peptidderivat
OA06421A (fr) Procédé de préparation de dérivés N-(vinblastinoyl-23) d'acides aminés et de peptides.
MY135057A (en) Dolastatin 15 derivatives
TR199701546T1 (xx) Kortikosteroid kaynakl� osteofeni'nin tedavisi i�in metod.
NO177845C (no) Fremgangsmåte for fremstilling av et preparat for öyedråper
TR199802534T2 (xx) Leptin (OB Protein) fragmanlar�
FI98510B (fi) Vateriitti ja menetelmä sen valmistamiseksi
SE9101838D0 (sv) Novel peptides and their use
ATE184798T1 (de) Hgh enthaltende pharmazeutische zubereitungen
SE9604593D0 (sv) Antimicrobially active polypeptides
HUT62585A (en) Process for producing 6-amino-octahydro-indolizinetriole derivatives and phqrmaceutical compositions comprising same as active ingredient
DK1074264T3 (da) Inhibitorer for neovaskularisering
ATE128871T1 (de) Verfahren zur behandlung von thrombocytopenie und dafür geeignete pharmazeutische zusammensetzungen.
DE59409413D1 (de) Verwendung von n,s-diacetylcystein-ethylester (dacee) zur herstellung eines medikaments zur behandlung viraler erkrankungen
HUT47374A (en) Fungicide compositions containing /2-cyano-2-oximino-acetyl/-aminoacid derivatives as active components and process for producing the active components
ES2052801T3 (es) Procedimiento diastereoselectivo para la preparacion de intermediarios utiles para la sintesis de derivados peptidicos.
NO922229L (no) Peptid derivativ, fremgangsmaate til fremstilling av dissefarmasoeytiske preparater som inneholder disse og fremgangsmaate for behandling av glaucoma
NZ516372A (en) Method for stabilising proteins in complex mixtures during their storage in aqueous solvents
DK87090A (da) Vasotocin-derivater og farmaceutiske midler indeholdende saadanne derivater
IT1243778B (it) Derivati salini dell'acido tauroursodesossicolico, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
FI944076A (fi) Menetelmä terapeuttisesti käytt¦kelpoisten N-(3-hydroksi-4-piperidinyyli)(dihydrobentsofuraani-, dihydro-2H-bentsopyraani- tai dihydrobentsodioksiini)karboksamidijohdannaisten valmistamiseksi ja välituote

Legal Events

Date Code Title Description
FD Application lapsed